SARS-CoV-2 variants: Impact on biological and clinical outcome
The severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) that was first identified in December 2019, in Wuhan, China was found to be the etiological agent for a novel respiratory infection that led to a Coronavirus Induced Disease named COVID-19. The disease spread to pandemic magnitudes wit...
Main Authors: | Shakuntala Mahilkar, Sachee Agrawal, Sakshi Chaudhary, Swapneil Parikh, Subash C. Sonkar, Dileep Kumar Verma, Vidushi Chitalia, Divya Mehta, Bidhan Chandra Koner, Neetu Vijay, Jayanthi Shastri, Sujatha Sunil |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-11-01
|
Series: | Frontiers in Medicine |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fmed.2022.995960/full |
Similar Items
-
Development and optimization of an in-house heterologous ELISA for detection of prednisolone drug in enzyme conjugates using spacers
by: Dinesh Kumar, et al.
Published: (2023-08-01) -
Pre-analytical, analytical, and post-analytical considerations while processing samples of COVID-19 patients: Perspective from a clinical chemistry laboratory in India
by: Saswati Das, et al.
Published: (2020-09-01) -
Evaluation of Performance of Detection of Immunoglobulin G and Immunoglobulin M Antibody Against Spike Protein of SARS-CoV-2 by a Rapid Kit in a Real-Life Hospital Setting
by: Monica Irungbam, et al.
Published: (2022-04-01) -
Antithyroid Antibodies and Fertility Outcome in Euthyroid Women Undergoing In Vitro Fertilisation
by: Aheibam Bidya Devi, et al.
Published: (2019-05-01) -
Gender variability in performance of multiple-choice question-based assessment on medical biochemistry topics among 1st year MBBS students
by: Elvia Jamatia, et al.
Published: (2023-01-01)